Johnson & Johnson Set to Acquire Verb Surgical Completely by First Half of Next Year


News provided by

Independent Tech & news media Writer

Jan 03, 2020, 11:40 EST


Elkland, United States, Jan 03, 2020, 11:40 /Comserve / -- Johnson & Johnson (NYSE: JNJ), an NYSE listed company that is engaged in development of medical devices entered into an agreement with Verb Surgical, Inc.

Image placeholder

Johnson & Johnson (NYSE: JNJ), an NYSE listed company that is engaged in development of medical devices entered into an agreement with Verb Surgical, Inc., another medical device company that was started as a result of partnership between Verily Life Sciences, a research arm of Alphabet, Inc. engaged in study of life sciences and Ethicon, a subsidiary of Johnson and Johnson company, engaged in the manufacture of surgical sutures and wound closure devices to acquire the balance stake remaining in Verb Surgical, Inc. Johnson & Johnson is expected to gain considerably from the four year old’s expertize that has been creating robotic-assisted surgical products. Moreover, the combined expertize of both these market players are anticipated to make medical interventions smarter and only minimally invasive.

Ashley McEvoy, Worldwide Chairman, Medical Devices, Johnson & Johnson stated as follows, “We have reached this important milestone thanks to the progress the Verb Surgical team has made with their digital surgery platform and the strong collaboration with Verily, Ethicon and the clinicians around the world who shared their passion, deep insights and clinical expertize. We are building a truly differentiated digital surgery ecosystem to change the standard of care for generations to come, and our collaboration with Verily has enabled us to advance our vision to help improve outcomes for patients around the world.

Johnson & Johnson, with its innovative robotics, machine learning, data analytics and others has managed to reinforce its portfolio on digital surgery. The company has managed to retain several companies under its belt that serve to complement its position in the market in various areas in science and medicine. Johnson & Johnson has been present in nearly every operating room of the world and they have been using surgery products that are leading in the market.

The Company had just completed the acquisition of Auris Health, Inc. earlier during the year. This has paved the way for Johnson & Johnson’s entry into digital surgery. VELYS Digital Surgery has shown the way in orthopedics, with a platform that consists of connected technologies that provide various insights on data for surgeons, patients and other connected systems across the healthcare sector at all stages of the surgery. The transaction is expected to be closed in the following year (i.e. 2020), subject to obtaining the customary conditions and other clearances.

Independent Tech & news media Writer


For more information, please contact:

Marlin Bode

Independent Tech & news media Writer
Email: bodemarlin@gmail.com
Tel: +1 814-302-1499

Related Links
https://www.comserveonline.com/



Also from this source


Microsoft and NTT to Form Multi-Year Strategic Alliance for Accelerating Digital Transformations

The arrangement aims at developing new digital solutions that are secure and reliable for making tra


Belgium gets a Manufacturing Facility in Europe – Clarus Signals Growth for European Region

Clarus had just made the official announcement about the opening of its manufacturing plant in Belgi